Phase 1 Bioavailability Study of SYR-322MET

Clinical trial NCT02508168 · COMPLETED

Trial details

NCT number: NCT02508168
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2016-04-01
Primary completion: 2016-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.